October 27, 2025 Forward Looking Statements and Risk Factors This document contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. When Welltower uses words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "pro forma," "estimate" or similar expressions that do not relate solely to historical matters, Welltower is making forward-looking statements. These statements include, among others, management's expectations regard ...

Q3 2025 Financial Performance - Revenue for Q3 2025 reached $4,100 million, a 5.2% increase AFx (actual foreign exchange rates) and 3.9% increase CFx (constant currency) compared to $3,896 million in Q3 2024[12] - Adjusted EBITDA for Q3 2025 was $949 million, a 1.1% increase AFx compared to $939 million in Q3 2024[12] - Adjusted Diluted EPS for Q3 2025 was $3.00, a 5.6% increase AFx compared to $2.84 in Q3 2024[12] - Net income attributable to IQVIA Holdings Inc was $331 million in Q3 2025, compared to $285 million in Q3 2024[31] Year-to-Date (YTD) Performance - YTD Revenue for 2025 reached $11,946 million, a 4.4% increase AFx and 3.7% increase CFx compared to $11,447 million in 2024[15] - YTD Adjusted EBITDA for 2025 was $2,742 million, compared to $2,688 million in 2024[17] - YTD Adjusted Diluted Earnings per Share was $8.50, compared to $8.02 in 2024[17] Segment Performance (Q3 2025) - Technology & Analytics Solutions revenue was $1,631 million, a 5.0% increase AFx compared to $1,554 million in Q3 2024[15] - Research & Development Solutions revenue was $2,260 million, a 4.5% increase AFx compared to $2,162 million in Q3 2024[15] - Contract Sales & Medical Solutions revenue was $209 million, a 16.1% increase AFx compared to $180 million in Q3 2024[15] R&D Solutions Bookings and Backlog - R&D Solutions backlog increased by 4.1% from $31.1 billion in Q3 2024 to $32.4 billion in Q3 2025[21] Balance Sheet and Cash Flow - Cash & Cash Equivalents totaled $1,814 million[23] - Free Cash Flow for Q3 2025 was $772 million[23] Full Year 2025 Guidance - The company projects full-year 2025 revenue between $16,150 million and $16,250 million[26] - The company projects full-year 2025 Adjusted EBITDA between $3,775 million and $3,800 million[26] - The company projects full-year 2025 Adjusted Diluted EPS between $11.85 and $11.95[26]

Third Quarter 2025 Financial Results Investor Presentation October 28, 2025 Group 1 Automotive 2025 Forward looking statements This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, which are statements related to future, not past, events and are based on our current expectations and assumptions regarding our business, the economy and other future conditions. In this context, the forward-looking statements often include statements ...

Financial Performance - The company's total assets reached $164 billion in 3Q25[9], with total deposits of $137 billion and total loans of $129 billion[6] - Total revenue for 3Q25 was a record $1681 million, a 208% year-over-year increase[9] - Net interest income increased by 222% year-over-year[9], reaching $1360 million in 3Q25, a 139% increase QoQ[12] - Diluted EPS was $002, while adjusted diluted EPS was $029[6]; Year-to-date EPS growth was 15% (GAAP) and 21% (Adjusted)[9] - The net interest margin improved to 365%, benefiting from higher average loan yields and purchase accounting accretion[13] Merger and Acquisition - Successfully completed the merger with Penns Woods on July 25, 2025, adding balance sheet scale with $164 billion in assets, $129 billion in loans, and $137 billion in deposits[19] - Total consideration paid for Penns Woods was $2338 million[18] - The merger is expected to achieve 234% EPS accretion in 2026[18] - Loan marks from the Penns Woods acquisition were $776 million, and core deposit intangibles were $480 million[18] Loan and Deposit Portfolio - Average loans grew by $132 billion QoQ, with commercial loans increasing by $177 million, or 84% QoQ and $460 million, or 253% YoY[30] - Average total deposits grew by $114 billion QoQ[37] - Cost of deposits remained flat at 155%[37] Outlook - The company expects to maintain a net interest margin in the mid-360s bps level in 4Q25, including projected contractual purchase accounting loan accretion of $19 million[89] - Noninterest income is expected to be in the range of $32 million to $33 million in 4Q25[89] - Noninterest expense is expected to be in the range of $102 million to $104 million in 4Q25[89]

Financial Performance - Q3 2025 Adjusted EBITDA was $254 million[6,9], with a 32% margin[9,26] - Free cash flow for Q3 2025 reached $139 million[6,9] - Through the first nine months of 2025, free cash flow totaled $419 million, representing a 48% conversion from Adjusted EBITDA[6] - $340 million was returned to shareholders in 2025, including an announced Q4 dividend of $0.50 per share[6] - Net debt stood at $1.499 billion[9] - Liquidity was reported at $1.01 billion[9] Contract Backlog and New Contracts - The current contract backlog is $7.0 billion[9,11] - Approximately $740 million in new contracts were secured[6,7] - 63% of floater days are committed for 2025[12] - 57% of jackup days are committed for 2026[12] Fleet Management - Fleet rationalization is underway, with Highlander and Reacher recently completed and Globetrotter II planned[6] Guidance - The company narrowed its 2025 revenue guidance to $3.225 billion - $3.275 billion[6,28] - Adjusted EBITDA guidance is $1.1 billion - $1.125 billion[28] - Capital additions, net of reimbursements, are guided at $425 million - $450 million[28]

Financial Performance - The company's total adjusted EBITDA for 3Q25 was $610.3 million[6], compared to $538.9 million in 3Q24[6] - For the nine months ended September 30, 2025, the adjusted net income attributable to Labcorp Holdings Inc was $1038.3 million, compared to $939.9 million for the same period in 2024[22] - The adjusted earnings per share for the three months ended September 30, 2025, was $4.18, compared to $3.50 for the same period in 2024[23] Revenue Analysis - Enterprise revenues, as reported, for 3Q25 were $3,564 million, an increase of 8.6% year-over-year[8] - Diagnostics Laboratories revenues, as reported, for 3Q25 were $2,770 million, an increase of 8.5% year-over-year[8] - Biopharma Laboratory Services revenues, as reported, for 3Q25 were $799 million, an increase of 8.3% year-over-year[8] - The company's revenue growth in Diagnostics Laboratories for 3Q25 was primarily driven by volume (4.7%) and price/mix (3.7%)[15] Outlook for 2025 - The company updated its 2025 revenue guidance for Labcorp Enterprise to a range of $13.97 billion to $14.05 billion, representing a growth of 7.4% to 8.0% versus 2024 results[18] - The company updated its 2025 adjusted EPS guidance to a range of $16.15 to $16.50, representing a growth of 10.8% to 13.2% versus 2024 results[18] Biopharma Laboratory Services - The trailing twelve-month net orders for Biopharma Laboratory Services ending September 30, 2025, were $3.34 billion, with a net book-to-bill ratio of 1.09x[17]

Financial Performance - The Hartford reported an 18.4% trailing 12-month core earnings ROE[11, 12] - Net investment income reached $759 million, before tax, driven by greater income from LPs, increased asset levels, and reinvesting at higher rates[13] - Core earnings were $1077 million, a 43% increase compared to $752 million in the third quarter of 2024[19] - Net income available to common stockholders was $1074 million, a 41% increase from $761 million in 3Q24[19] - Core earnings per diluted share increased by 49% to $3.78, compared to $2.53 in 3Q24[19] Segment Results - Business Insurance net written premiums grew by 9% in 3Q25[11], reaching $3.6 billion[20, 21], with Small Business up 11% and Middle & Large Business up 10%[20] - Business Insurance combined ratio improved to 88.8[18, 20, 29] from 92.2 in 3Q24[29] - Personal Insurance written premiums increased by 2% to $987 million[20, 31] - Personal Insurance combined ratio improved to 88.7[18, 20, 31, 34] from 102.5 in 3Q24[31] - Employee Benefits core earnings margin was 8.3%[18, 20, 35], with fully insured ongoing premiums remaining flat at $1.6 billion[20, 35, 40] - Hartford Funds reported core earnings of $53 million, up from $47 million in 3Q24[19, 42] Capital Management - The company repurchased $400 million of shares and paid $147 million in common stockholder dividends in 3Q25[18, 64] - A 15% increase to the quarterly common dividend per share was announced[18, 64] - Book value per diluted share (ex AOCI) increased to $70.92[16, 59, 63]

Financial Performance - Net long-term inflows reached $28.9 billion, representing an annualized organic growth of 7.9%[17] - Ending AUM hit a record $2.1 trillion[17] - Net revenues increased by 7.4% to $1186.3 million, while adjusted operating expenses increased by 3.3% to $780.2 million year-over-year[16] - Adjusted diluted EPS increased by 38.6% year-over-year to $0.61[16] - The adjusted operating margin improved by 260 basis points year-over-year to 34.2%[16] Balance Sheet and Capital Management - $260 million of bank term loans were repaid in Q3'25[8] - Share buybacks of $25 million, representing 1.2 million shares, were executed[17] - Ending long-term AUM grew 16% over the third quarter of 2024[17] AUM and Flows by Investment Capability - ETFs and Index strategies saw net long-term inflows of $21.4 billion and an ending AUM of $605.7 billion[9] - Fundamental Fixed Income experienced net long-term inflows of $4.1 billion and an ending AUM of $308.8 billion[9] - Fundamental Equities had net outflows of $5.0 billion with an ending AUM of $299.6 billion[9] - China JV & India saw net long-term inflows of $8.1 billion and an ending AUM of $136.8 billion[9]

Financial Performance & Shareholder Returns - D.R Horton achieved home sales revenues of $31.4 billion from 84,863 homes closed in fiscal year 2025[12, 90] - The company returned $4.8 billion to shareholders through repurchases and dividends in FY25[9, 86] - D.R Horton repurchased 30.7 million shares of common stock for $4.3 billion, reducing outstanding share count by 9% year-over-year[51, 56, 86] - The company paid cash dividends of $494.8 million, which is $1.60 per common share, a 33% increase compared to the prior year[56, 86] Operational Highlights - D.R Horton's homebuilding operations generated revenues of $8.5 billion from 23,368 homes closed in Q4 2025[84, 87] - The average sales price of homes closed was $370.4K[9, 24] - 72% of homes closed were priced below $400k[23] - D.R Horton's financial services segment, primarily DHI Mortgage, had an 81% mortgage capture rate of D.R Horton homebuyers[16, 31, 81] Future Outlook - For fiscal year 2026, D.R Horton expects consolidated revenues to be in the range of $33.5 billion to $35.0 billion and between 86,000 and 88,000 homes closed[42] - The company anticipates repurchasing approximately $2.5 billion of common stock and paying out ~$500 million in dividends in fiscal 2026[42, 51]

Q3 2025 Financial Results Conference call | October 28, 2025 www.materialise.com | NASDAQ: MTLS #0058a5 #00b1ea Right mouse click: Send or bring your image or shape to the front/back #0084c8 #f0b323 Titel : Arial Bold Sub titel: Arial regular Text: Arial regular Colors Font Useful Tools: Add image Add video Home -> Arrange: Align objects Click on the graph: Click on the tab -> Change colours Safe Harbor Summary This presentation contains forward-looking statements within the meaning of Section 27A of the Se ...